tirzepatide for children Efficacy and safety of in and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial Medscape - The SURPASS-PEDS trial

The medication also appears to influence food reward pathways in the brain

On the flip side, GLP-1s are linked to an increased risk of gastrointestinal disorders, arthritis, low blood pressure, fainting, drug-induced pancreatitis, nephrolithiasis (kidney stones), and interstitial nephritis

Emerging oral peptide technologies exist, but as of 2024, injection remains the standard

Discover if you qualify for our prescription weight loss medications and begin your journey toward a healthier, more vibrant you

If you encounter a feature like quick bet history, customizable wager presets, or smart search filters for volatility and RTP, take it as a sign of thoughtful engineering